(NYSE: WST) West Pharmaceutical Services's forecast annual revenue growth rate of 10.28% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 6.64%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 9.23%.
West Pharmaceutical Services's revenue in 2023 is $2,909,000,000.On average, 3 Wall Street analysts forecast WST's revenue for 2023 to be $236,320,697,803, with the lowest WST revenue forecast at $233,403,798,115, and the highest WST revenue forecast at $241,243,891,438. On average, 2 Wall Street analysts forecast WST's revenue for 2024 to be $260,261,114,974, with the lowest WST revenue forecast at $255,783,970,085, and the highest WST revenue forecast at $264,738,259,863.
In 2025, WST is forecast to generate $290,844,512,068 in revenue, with the lowest revenue forecast at $290,844,512,068 and the highest revenue forecast at $290,844,512,068.